FDA warns of eye drops that could cause infection from several major brands

As the fall season settles in across the Garden State, many residents find themselves contending with the yearly menace of autumn allergies. However, this year, allergy sufferers in New Jersey must also be wary of certain over-the-counter eye drop products that the led the U.S. Food and Drug Administration has recently issue a warning.

The FDA has expressed concerns that these eye drop products branded Leader may pose a potential risk of eye infections, which could result in partial vision loss or blindness.

The products in question, marketed under several well-known brands, have come under scrutiny due to potential contamination issues. The brands affected by the FDA’s warning include CVS Health, Leader (Cardinal Health), Rugby (Cardinal Health), Rite Aid, Target Up & Up, and Velocity Pharma.

These products, primarily used to alleviate common eye irritations, are intended to be sterile. However, the FDA has voiced its concern that ophthalmic drug products, especially when applied to the eyes, bypass some of the body’s natural defenses, thereby heightening the risk of harm to users. 

In light of these safety concerns, CVS, Rite Aid, and Target have proactively taken action to protect consumers by removing the affected eye drop products from their store shelves and websites.

NJ newsOur guide to New Jersey’s 2023 elections for Legislature, local offices and school boards

Consumers in New Jersey and across the nation are urged not to purchase any of these eye drops, especially those branded as Leader, Rugby, and Velocity. While CVS, Rite Aid, and Target have already removed the products from their shelves, there is still a possibility that Leader, Rugby, and Velocity products may be available for purchase in other stores and online outlets.

The FDA’s warning comes at a time when many New Jersey residents are grappling with fall allergies. Ragweed pollen, mold spores, and other allergens are prevalent during this season, often leading to itchy, watery eyes, sneezing, and other bothersome symptoms. The combination of fall allergies and the potential risks associated with certain over-the-counter eye drops underscores the importance of being vigilant about the products used to address allergy-related discomfort.

Allergy sufferers in New Jersey are advised to exercise caution and consider alternatives if they experience eye discomfort or allergies this fall. In addition to heeding the FDA’s warning regarding certain eye drop products, individuals are encouraged to consult with healthcare professionals for guidance on safe and effective remedies for allergy-related eye issues.

As the autumn season unfolds allergy sufferers in New Jersey are advised to exercise caution and consider alternatives if they experience eye discomfort or allergies this fall. With the FDA’s concerns on the radar, it is essential for consumers to prioritize their eye health and make informed choices to safeguard their vision.